EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

US food allergy patients’ experiences, priorities, and needs: A qualitative study

Elisabeth Oehrlein, Silke C Schoch, Omar A Escontrías, Melanie Carver, Sanaz Eftekhari, Jessica Marvel, Chris Leo Pashos, Michael Pistiner, Randall Rutta, Jill Voss, Joe Vandigo

Journal of Allergy and Clinical Immunology: Global · 2025-08 · 4 (3) · 100482

DOI: 10.1016/j.jacig.2025.100482 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2025-08. Verfasst von Elisabeth Oehrlein und 10 weiteren Autor:innen. Beteiligte Einrichtung: Applied Patient Experience, LLC, Washington, DC. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Pharmaceuticals Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding patient experiences with food allergies (FAs) is essential for developing treatments that meet patients' needs and aiding clinicians in optimizing care.

Objective

We sought to provide clinicians and researchers with an inclusive view of IgE-mediated FA patients' experiences, including (1) FA's natural history, including signs, symptoms, health system experiences, and diagnosis pathways; (2) the disease's burden and psychosocial impacts on individuals and families; (3) perspectives on treatment attributes, benefits, and clinical trial participation; and (4) topics and resources patients and caregivers seek regarding FAs. Enhanced understanding of these challenges and opportunities can improve personalized care and patient outcomes.

Methods

We conducted virtual interviews with 81 US residents with at least 1 physician-confirmed IgE-mediated FA. Interviews lasted up to 60 minutes. All participants were required to self-report a history of severe allergic reactions. Recruitment was via social media, health care providers, and patient advocacy organizations.

Results

Most participants had multiple FAs, with peanuts and/or tree nuts (86%) being the most common. Common reaction types were skin/mouth (91%), respiratory (65%), and gastrointestinal (53%). Key diagnosis pathways included seeking urgent/emergency care after severe reactions and discussing moderate symptoms with primary care doctors. Barriers to diagnosis included long allergist wait times, travel, and other commitments. Most participants with epinephrine autoinjectors felt confident using them due to prior training. FA impacts varied, from minor daily disruptions to significant emotional, social, educational, and career challenges, mainly due to allergen avoidance efforts. Most participants (59%) showed an interest in clinical trials, influenced by potential risks and benefits, trial type, location, accessibility, and child willingness. Despite valuing epinephrine autoinjectors, participants noted unmet needs such as inconvenience, high costs, short expiration dates, and shortages. Desired treatment benefits included proactive treatments enabling allergen ingestion without symptoms and more information on FA management.

Conclusions

This study offers insights into the diverse needs of IgE-mediated FA patients, highlighting the importance of comprehensive clinician awareness to enhance personalized care, optimize patient experiences, and improve outcomes. Addressing financial barriers and unmet needs through a team approach, clear communication, psychosocial support, and accessible resources is essential.

Schlagwörter

Stichwörter der Autor:innen

IgE-mediated FAsdiagnosis pathwayshealth system experiencespatient experiencespersonalized carepsychosocial impact

Autor:innen und Institutionen

  • Applied Patient Experience, LLC, Washington, DC.
  • National Health Council, Washington, DC.
  • Asthma and Allergy Foundation of America, Arlington, Va.
  • Novartis Pharmaceuticals, East Hanover, NJ.
  • Independent Advisor, Boston, Mass.
  • Mass General for Children, Boston, Mass.

Förderung

  • Novartis Pharmaceuticals Corporation

Zitieren

APA

Oehrlein, E., Schoch, S. C., Escontrías, O. A., Carver, M., Eftekhari, S., Marvel, J., Pashos, C. L., Pistiner, M., Rutta, R., Voss, J., & Vandigo, J. (2025). US food allergy patients’ experiences, priorities, and needs: A qualitative study. Journal of Allergy and Clinical Immunology: Global, 4(3), 100482. https://doi.org/10.1016/j.jacig.2025.100482

Vancouver

Oehrlein E, Schoch SC, Escontrías OA, Carver M, Eftekhari S, Marvel J, et al. US food allergy patients’ experiences, priorities, and needs: A qualitative study. Journal of Allergy and Clinical Immunology: Global. 2025;4(3):100482. doi:10.1016/j.jacig.2025.100482

BibTeX
@article{Oehrlein2025,
  author = {Oehrlein, Elisabeth and Schoch, Silke C and Escontrías, Omar A and Carver, Melanie and Eftekhari, Sanaz and Marvel, Jessica and Pashos, Chris Leo and Pistiner, Michael and Rutta, Randall and Voss, Jill and Vandigo, Joe},
  title = {US food allergy patients’ experiences, priorities, and needs: A qualitative study},
  journal = {Journal of Allergy and Clinical Immunology: Global},
  year = {2025},
  volume = {4},
  number = {3},
  pages = {100482},
  doi = {10.1016/j.jacig.2025.100482}
}
Kostenlos starten →